Muscle at the junction
Where next generation sequencing is sending us
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Skeletal muscle membrane stability is dependent on the actions of sodium, calcium, and chloride channels to appropriately gate ion activity. The sodium channel Nav1.4 in particular has been recognized as having a critical role in the gating of ion current in skeletal muscle.1 Mutations in Nav1.4 due to variants in the SCN4A gene result in a variety of phenotypes including hyperkalemic and hypokalemic periodic paralysis, paramyotonia congenita, and congenital myasthenic syndrome with mixed dominant and recessive inheritance. Dominantly inherited disorders such as hypokalemic periodic paralysis result in leaky sodium channels that in turn results in transient episodic weakness that often presents early in childhood.2 Eventually, many of these patients develop myopathic features including fixed proximal weakness. Dominant mutations in SCN4A that result in increased sodium influx cause hyperkalemic periodic paralysis and paramyotonia congenita phenotypes.3 In contrast, loss-of-function mutations in SCN4A result in a more severe congenital myasthenic syndrome with disruption of the neuromuscular junction. This constellation of rare disorders, as the result of either loss of function or gain of function of the sodium channel, shares several characteristic features: (1) transient, fluctuating symptoms (either weakness or myotonia); (2) progression to fixed weakness; and (3) rare occurrence. What is distinct between the gain-of-function and loss-of-function mutations are those disorders that involve muscle excitability (such as paramyotonia congenita) and those disorders that impair muscle contraction, either at the neuromuscular junction or muscle membrane itself (congenital myasthenic syndrome and hypokalemic periodic paralysis). With the constellation of syndromes affected by mutations in SCN4A, it is not clear if we have completely identified the spectrum of allelic disorders caused by mutations in SCN4A. In addition, the mechanism separating the gain-of-function from loss-of-function mutations is incompletely understood.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
See page 603
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Myasthenic congenital myopathy from recessive mutations at a single residue in NaV1.4Nathaniel Elia, Johanna Palmio, Marisol Sampedro Castañeda et al.Neurology, March 01, 2019 -
Articles
Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotoniaJadon Webb, Stephen C. Cannon et al.Neurology, September 26, 2007 -
Article
Prevalence study of genetically defined skeletal muscle channelopathies in EnglandAlejandro Horga, Dipa L. Raja Rayan, Emma Matthews et al.Neurology, March 20, 2013 -
Article
Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in SCN4A geneJohanna Palmio, Satu Sandell, Michael G. Hanna et al.Neurology, March 22, 2017